A secreção residual do peptídeo C faz diferença no tratamento do diabetes melito tipo 1?

5Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Type 1 diabetes is a chronic disease characterized by progressive destruction of the pancreatic β cells, what leads to insulin deficiency and hyperglycemia. However, a significant secretory function may persist for long periods in a few patients, what is clinically evident through the detection of serum C peptide. This phenomenon might reduce the risk of chronic complications, severe hypoglycemias and allow easier metabolic control. It is possible that these advantages are caused, at least partially, by C peptide itself, acting directly in its target tissues. Copyright© ABE&M.

Author supplied keywords

Cite

CITATION STYLE

APA

Rodacki, M., Milech, A., & De Oliveira, J. E. P. (2008, March). A secreção residual do peptídeo C faz diferença no tratamento do diabetes melito tipo 1? Arquivos Brasileiros de Endocrinologia e Metabologia. https://doi.org/10.1590/S0004-27302008000200020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free